Name
Mediford Corporation
What We Do
Mediford Corporation, a leading CRO based in Japan, provides comprehensive support for drug discovery and development. With over 45 years of experience, we offer services that cover the entire process, from the exploratory phase to pre-clinical and clinical studies.
Our facilities, fully compliant with GLP and accredited by AAALAC International, are equipped to support a wide range of pre-clinical study services, focusing on evaluating the efficacy and safety of pharmaceuticals and regenerative medicine products. Our laboratory capabilities include bioanalysis such as biomarker analysis, as well as tailored solutions designed to meet the specific requirements of clinical testing.
We are committed to contributing to the development of innovative drugs by applying the latest analytical technologies and offering customized services to global pharmaceutical companies, ventures and analytical laboratories.
Mediford Corporation is a subsidiary of PHC Holdings Corporation (TSE 6523).
Our facilities, fully compliant with GLP and accredited by AAALAC International, are equipped to support a wide range of pre-clinical study services, focusing on evaluating the efficacy and safety of pharmaceuticals and regenerative medicine products. Our laboratory capabilities include bioanalysis such as biomarker analysis, as well as tailored solutions designed to meet the specific requirements of clinical testing.
We are committed to contributing to the development of innovative drugs by applying the latest analytical technologies and offering customized services to global pharmaceutical companies, ventures and analytical laboratories.
Mediford Corporation is a subsidiary of PHC Holdings Corporation (TSE 6523).
Website
Product or Service Categories (15)
Pathology, Pharmaceutical Toxicology, Toxicokinetics, ADME (Absorption/Distribution/Metabolism/Excretion), CRO—Contract Research Organization, GLP—Good Laboratory Practice Services, LC/MS—Liquid Chromatography/Mass Spectroscopy, Bioanalytical Services, Inhalation Toxicology
Address
36-1, Shimizu-cho
Itabashi-ku, Tokyo 1740053
Japan
Itabashi-ku, Tokyo 1740053
Japan